Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00583947 · ClinicalTrials.gov registry record · Phase 2
A Safety and Tolerability Study of Arformoterol Tartrate Inhalation Solution in Pediatric Subjects
A Phase 2 study, sponsored by Sumitomo Pharma America.
- Completed
- Registry status
- Phase 2
- Development phase
- 53
- Enrollment target
NCT00583947 is a Phase 2 study that has completed, run by Sumitomo Pharma America. The registered enrollment target is 53 participants.
The verdict
NCT00583947, a Phase 2 study, has completed, sponsored by Sumitomo Pharma America.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 53 participants
- Enrollment target
Study Summary
To determine the safety and tolerability of Arformoterol Tartrate in children with asthma
Interventions
- DRUG levalbuterol
- DRUG arformoterol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2008-01 |
| Est. Completion | 2008-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00583947
The ClinicalTrials.gov registry entry for NCT00583947 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 53 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sumitomo Pharma America, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which levalbuterol is the first listed.
NCT00583947 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00583947 about?
NCT00583947 is a clinical study titled "A Safety and Tolerability Study of Arformoterol Tartrate Inhalation Solution in Pediatric Subjects". To determine the safety and tolerability of Arformoterol Tartrate in children with asthma
What is the current status of trial NCT00583947?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 53 participants. The study started on 2008-01. Estimated completion is 2008-12.
What interventions are being tested in trial NCT00583947?
The interventions under investigation include: levalbuterol (DRUG), arformoterol (DRUG).
Who is sponsoring clinical trial NCT00583947?
This trial is sponsored by Sumitomo Pharma America, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.